A new study from the University of California regarding the study of heart attack factors illustrated an interesting new relationship between having a high rate of a particular group of neuropeptides and the risk of dying from a heart attack. In particular, a team of specialists studied this relationship through the prism of a wide range of cardiovascular diseases, and made a special emphasis on the consideration of class Y neuropeptides – which were the main culprits of the increased risk of dying from a heart attack shortly after a person is generally diagnosed with heart problems .
The study also involved a team of experts in the cardiovascular system from the American Heart Association, which is professionally involved in the study of a wide variety of heart syndromes and conditions. It turned out that those patients suffering from one or another serious heart problem and who have an increased rate of neuropeptide Y production, on average, have an increased chance of dying from a heart attack in the period from one year to three years shortly after diagnosis.
The study collected data from 105 patients over the past five years, who mainly suffered from arrhythmic syndromes and who had an increased rate of production of this neuropeptide. It is worth noting that the biomarker presented, although it is indicative, is still not the only one in the study, although so far the scientific team is in no hurry to share with users specific considerations and conclusions regarding the real situation.
Be that as it may, it becomes clear that the results of this study may well be decisive for the compilation of a conceptually new type of treatment for this kind of heart problems. A more accurate diagnosis of the likelihood of early mortality due to disruption of the cardiovascular system also in theory will allow a much more accurate cope with the choice of the most rational and effective treatment.